These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 11263528

  • 1. Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis.
    Agard C, Ligeza C, Dupas B, Izembart A, El Kouri C, Moullier P, Ferry N.
    Cancer Gene Ther; 2001 Feb; 8(2):128-36. PubMed ID: 11263528
    [Abstract] [Full Text] [Related]

  • 2. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ, Gore M, Smiley WR, Kanemitsu MY, Jolly DJ, Read SB, Nicholas T, Kruse CA.
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [Abstract] [Full Text] [Related]

  • 3. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO.
    Cancer Gene Ther; 1996 Jan; 3(2):99-106. PubMed ID: 8729908
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D.
    Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
    Mäkinen K, Loimas S, Wahlfors J, Alhava E, Jänne J.
    J Gene Med; 2000 Mar; 2(5):361-7. PubMed ID: 11045430
    [Abstract] [Full Text] [Related]

  • 6. Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy.
    Loimas S, Toppinen MR, Visakorpi T, Jänne J, Wahlfors J.
    Cancer Gene Ther; 2001 Feb; 8(2):137-44. PubMed ID: 11263529
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM.
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K, Sandmair AM, Turunen M, Vanninen R, Vainio P, Kauppinen R, Johansson R, Vapalahti M, Ylä-Herttuala S.
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
    He J, Chen Y, Li H, Lu Y, Yan Y, Tan X.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
    Su H, Lu R, Ding R, Kan YW.
    Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
    [Abstract] [Full Text] [Related]

  • 14. Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene.
    Carrió M, Romagosa A, Mercadé E, Mazo A, Nadal M, Gómez-Foix AM, Fillat C.
    Gene Ther; 1999 Apr; 6(4):547-53. PubMed ID: 10476214
    [Abstract] [Full Text] [Related]

  • 15. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM, Tenhunen A, Pasanen T, Meriläinen O, Pellinen R, Mäkinen K, Alhava E, Wahlfors J.
    Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
    [Abstract] [Full Text] [Related]

  • 16. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
    Miura F, Moriuchi S, Maeda M, Sano A, Maruno M, Tsanaclis AM, Marino R, Glorioso JC, Yoshimine T.
    Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
    [Abstract] [Full Text] [Related]

  • 17. [In vitro and in vivo bystander effect of adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene].
    Gao G, Huang T, Chen S.
    Zhonghua Wai Ke Za Zhi; 2002 Apr; 40(4):301-3. PubMed ID: 12133366
    [Abstract] [Full Text] [Related]

  • 18. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y, Lu G, Xiao Y, Zeng F, Zhang Q, Xiong P, Feng W.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1484-7. PubMed ID: 12509912
    [Abstract] [Full Text] [Related]

  • 19. A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect.
    Princen F, Robe P, Lechanteur C, Mesnil M, Rigo JM, Gielen J, Merville MP, Bours V.
    Clin Cancer Res; 1999 Nov 10; 5(11):3639-44. PubMed ID: 10589781
    [Abstract] [Full Text] [Related]

  • 20. Gene therapy against an experimental glioma using adeno-associated virus vectors.
    Okada H, Miyamura K, Itoh T, Hagiwara M, Wakabayashi T, Mizuno M, Colosi P, Kurtzman G, Yoshida J.
    Gene Ther; 1996 Nov 10; 3(11):957-64. PubMed ID: 8940635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.